Global Engineered Cell Therapy Supply, Demand and Key Producers, 2023-2029
The global Engineered Cell Therapy market size is expected to reach $ 10490 million by 2029, rising at a market growth of 13.4% CAGR during the forecast period (2023-2029).
Engineered cell therapy is designed to improve the ability of a patient's immune system to fight cancer by reintroducing improved immune cells. They are manufactured by collecting specific immune cells, called T cells, from the blood of the patient.
This report studies the global Engineered Cell Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Engineered Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Engineered Cell Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Engineered Cell Therapy total market, 2018-2029, (USD Million)
Global Engineered Cell Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Engineered Cell Therapy total market, key domestic companies and share, (USD Million)
Global Engineered Cell Therapy revenue by player and market share 2018-2023, (USD Million)
Global Engineered Cell Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Engineered Cell Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Engineered Cell Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Stryker, Zimmer Inc., Acelity, Allergan, Cook Medical, Baxter International, Organovo Holdings Inc and Integra LifeSciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Engineered Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Engineered Cell Therapy Market, By Region:
1. How big is the global Engineered Cell Therapy market?
2. What is the demand of the global Engineered Cell Therapy market?
3. What is the year over year growth of the global Engineered Cell Therapy market?
4. What is the total value of the global Engineered Cell Therapy market?
5. Who are the major players in the global Engineered Cell Therapy market?
6. What are the growth factors driving the market demand?
Engineered cell therapy is designed to improve the ability of a patient's immune system to fight cancer by reintroducing improved immune cells. They are manufactured by collecting specific immune cells, called T cells, from the blood of the patient.
This report studies the global Engineered Cell Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Engineered Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Engineered Cell Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Engineered Cell Therapy total market, 2018-2029, (USD Million)
Global Engineered Cell Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Engineered Cell Therapy total market, key domestic companies and share, (USD Million)
Global Engineered Cell Therapy revenue by player and market share 2018-2023, (USD Million)
Global Engineered Cell Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Engineered Cell Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Engineered Cell Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Stryker, Zimmer Inc., Acelity, Allergan, Cook Medical, Baxter International, Organovo Holdings Inc and Integra LifeSciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Engineered Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Engineered Cell Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Synthetic
- Biologically Derived
- Others
- Research Institutes
- Biotechnological Organizations
- Diagnostic Centres
- Medtronic
- Stryker
- Zimmer Inc.
- Acelity
- Allergan
- Cook Medical
- Baxter International
- Organovo Holdings Inc
- Integra LifeSciences
- DePuy Synthes
- B. Braun Melsungen AG
- AbbVie
- Becton
- Dickinson and Company
- Organogenesis Inc.
- Athersys Inc.
- ReproCell Inc.
- RTI Surgical Inc.
- Tissue Regenix Group Plc
- RepliCel.
1. How big is the global Engineered Cell Therapy market?
2. What is the demand of the global Engineered Cell Therapy market?
3. What is the year over year growth of the global Engineered Cell Therapy market?
4. What is the total value of the global Engineered Cell Therapy market?
5. Who are the major players in the global Engineered Cell Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Engineered Cell Therapy Introduction
1.2 World Engineered Cell Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Engineered Cell Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Engineered Cell Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Engineered Cell Therapy Market Size (2018-2029)
1.3.3 China Engineered Cell Therapy Market Size (2018-2029)
1.3.4 Europe Engineered Cell Therapy Market Size (2018-2029)
1.3.5 Japan Engineered Cell Therapy Market Size (2018-2029)
1.3.6 South Korea Engineered Cell Therapy Market Size (2018-2029)
1.3.7 ASEAN Engineered Cell Therapy Market Size (2018-2029)
1.3.8 India Engineered Cell Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Engineered Cell Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Engineered Cell Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Engineered Cell Therapy Consumption Value (2018-2029)
2.2 World Engineered Cell Therapy Consumption Value by Region
2.2.1 World Engineered Cell Therapy Consumption Value by Region (2018-2023)
2.2.2 World Engineered Cell Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Engineered Cell Therapy Consumption Value (2018-2029)
2.4 China Engineered Cell Therapy Consumption Value (2018-2029)
2.5 Europe Engineered Cell Therapy Consumption Value (2018-2029)
2.6 Japan Engineered Cell Therapy Consumption Value (2018-2029)
2.7 South Korea Engineered Cell Therapy Consumption Value (2018-2029)
2.8 ASEAN Engineered Cell Therapy Consumption Value (2018-2029)
2.9 India Engineered Cell Therapy Consumption Value (2018-2029)
3 WORLD ENGINEERED CELL THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Engineered Cell Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Engineered Cell Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Engineered Cell Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Engineered Cell Therapy in 2022
3.3 Engineered Cell Therapy Company Evaluation Quadrant
3.4 Engineered Cell Therapy Market: Overall Company Footprint Analysis
3.4.1 Engineered Cell Therapy Market: Region Footprint
3.4.2 Engineered Cell Therapy Market: Company Product Type Footprint
3.4.3 Engineered Cell Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Engineered Cell Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Engineered Cell Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Engineered Cell Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Engineered Cell Therapy Consumption Value Comparison
4.2.1 United States VS China: Engineered Cell Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Engineered Cell Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Engineered Cell Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Engineered Cell Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Engineered Cell Therapy Revenue, (2018-2023)
4.4 China Based Companies Engineered Cell Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Engineered Cell Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Engineered Cell Therapy Revenue, (2018-2023)
4.5 Rest of World Based Engineered Cell Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Engineered Cell Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Engineered Cell Therapy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Engineered Cell Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Synthetic
5.2.2 Biologically Derived
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Engineered Cell Therapy Market Size by Type (2018-2023)
5.3.2 World Engineered Cell Therapy Market Size by Type (2024-2029)
5.3.3 World Engineered Cell Therapy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Engineered Cell Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Research Institutes
6.2.2 Biotechnological Organizations
6.2.3 Diagnostic Centres
6.3 Market Segment by Application
6.3.1 World Engineered Cell Therapy Market Size by Application (2018-2023)
6.3.2 World Engineered Cell Therapy Market Size by Application (2024-2029)
6.3.3 World Engineered Cell Therapy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medtronic
7.1.1 Medtronic Details
7.1.2 Medtronic Major Business
7.1.3 Medtronic Engineered Cell Therapy Product and Services
7.1.4 Medtronic Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Medtronic Recent Developments/Updates
7.1.6 Medtronic Competitive Strengths & Weaknesses
7.2 Stryker
7.2.1 Stryker Details
7.2.2 Stryker Major Business
7.2.3 Stryker Engineered Cell Therapy Product and Services
7.2.4 Stryker Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Stryker Recent Developments/Updates
7.2.6 Stryker Competitive Strengths & Weaknesses
7.3 Zimmer Inc.
7.3.1 Zimmer Inc. Details
7.3.2 Zimmer Inc. Major Business
7.3.3 Zimmer Inc. Engineered Cell Therapy Product and Services
7.3.4 Zimmer Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Zimmer Inc. Recent Developments/Updates
7.3.6 Zimmer Inc. Competitive Strengths & Weaknesses
7.4 Acelity
7.4.1 Acelity Details
7.4.2 Acelity Major Business
7.4.3 Acelity Engineered Cell Therapy Product and Services
7.4.4 Acelity Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Acelity Recent Developments/Updates
7.4.6 Acelity Competitive Strengths & Weaknesses
7.5 Allergan
7.5.1 Allergan Details
7.5.2 Allergan Major Business
7.5.3 Allergan Engineered Cell Therapy Product and Services
7.5.4 Allergan Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Allergan Recent Developments/Updates
7.5.6 Allergan Competitive Strengths & Weaknesses
7.6 Cook Medical
7.6.1 Cook Medical Details
7.6.2 Cook Medical Major Business
7.6.3 Cook Medical Engineered Cell Therapy Product and Services
7.6.4 Cook Medical Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Cook Medical Recent Developments/Updates
7.6.6 Cook Medical Competitive Strengths & Weaknesses
7.7 Baxter International
7.7.1 Baxter International Details
7.7.2 Baxter International Major Business
7.7.3 Baxter International Engineered Cell Therapy Product and Services
7.7.4 Baxter International Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Baxter International Recent Developments/Updates
7.7.6 Baxter International Competitive Strengths & Weaknesses
7.8 Organovo Holdings Inc
7.8.1 Organovo Holdings Inc Details
7.8.2 Organovo Holdings Inc Major Business
7.8.3 Organovo Holdings Inc Engineered Cell Therapy Product and Services
7.8.4 Organovo Holdings Inc Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Organovo Holdings Inc Recent Developments/Updates
7.8.6 Organovo Holdings Inc Competitive Strengths & Weaknesses
7.9 Integra LifeSciences
7.9.1 Integra LifeSciences Details
7.9.2 Integra LifeSciences Major Business
7.9.3 Integra LifeSciences Engineered Cell Therapy Product and Services
7.9.4 Integra LifeSciences Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Integra LifeSciences Recent Developments/Updates
7.9.6 Integra LifeSciences Competitive Strengths & Weaknesses
7.10 DePuy Synthes
7.10.1 DePuy Synthes Details
7.10.2 DePuy Synthes Major Business
7.10.3 DePuy Synthes Engineered Cell Therapy Product and Services
7.10.4 DePuy Synthes Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 DePuy Synthes Recent Developments/Updates
7.10.6 DePuy Synthes Competitive Strengths & Weaknesses
7.11 B. Braun Melsungen AG
7.11.1 B. Braun Melsungen AG Details
7.11.2 B. Braun Melsungen AG Major Business
7.11.3 B. Braun Melsungen AG Engineered Cell Therapy Product and Services
7.11.4 B. Braun Melsungen AG Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 B. Braun Melsungen AG Recent Developments/Updates
7.11.6 B. Braun Melsungen AG Competitive Strengths & Weaknesses
7.12 AbbVie
7.12.1 AbbVie Details
7.12.2 AbbVie Major Business
7.12.3 AbbVie Engineered Cell Therapy Product and Services
7.12.4 AbbVie Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 AbbVie Recent Developments/Updates
7.12.6 AbbVie Competitive Strengths & Weaknesses
7.13 Becton
7.13.1 Becton Details
7.13.2 Becton Major Business
7.13.3 Becton Engineered Cell Therapy Product and Services
7.13.4 Becton Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Becton Recent Developments/Updates
7.13.6 Becton Competitive Strengths & Weaknesses
7.14 Dickinson and Company
7.14.1 Dickinson and Company Details
7.14.2 Dickinson and Company Major Business
7.14.3 Dickinson and Company Engineered Cell Therapy Product and Services
7.14.4 Dickinson and Company Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Dickinson and Company Recent Developments/Updates
7.14.6 Dickinson and Company Competitive Strengths & Weaknesses
7.15 Organogenesis Inc.
7.15.1 Organogenesis Inc. Details
7.15.2 Organogenesis Inc. Major Business
7.15.3 Organogenesis Inc. Engineered Cell Therapy Product and Services
7.15.4 Organogenesis Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Organogenesis Inc. Recent Developments/Updates
7.15.6 Organogenesis Inc. Competitive Strengths & Weaknesses
7.16 Athersys Inc.
7.16.1 Athersys Inc. Details
7.16.2 Athersys Inc. Major Business
7.16.3 Athersys Inc. Engineered Cell Therapy Product and Services
7.16.4 Athersys Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Athersys Inc. Recent Developments/Updates
7.16.6 Athersys Inc. Competitive Strengths & Weaknesses
7.17 ReproCell Inc.
7.17.1 ReproCell Inc. Details
7.17.2 ReproCell Inc. Major Business
7.17.3 ReproCell Inc. Engineered Cell Therapy Product and Services
7.17.4 ReproCell Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 ReproCell Inc. Recent Developments/Updates
7.17.6 ReproCell Inc. Competitive Strengths & Weaknesses
7.18 RTI Surgical Inc.
7.18.1 RTI Surgical Inc. Details
7.18.2 RTI Surgical Inc. Major Business
7.18.3 RTI Surgical Inc. Engineered Cell Therapy Product and Services
7.18.4 RTI Surgical Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 RTI Surgical Inc. Recent Developments/Updates
7.18.6 RTI Surgical Inc. Competitive Strengths & Weaknesses
7.19 Tissue Regenix Group Plc
7.19.1 Tissue Regenix Group Plc Details
7.19.2 Tissue Regenix Group Plc Major Business
7.19.3 Tissue Regenix Group Plc Engineered Cell Therapy Product and Services
7.19.4 Tissue Regenix Group Plc Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Tissue Regenix Group Plc Recent Developments/Updates
7.19.6 Tissue Regenix Group Plc Competitive Strengths & Weaknesses
7.20 RepliCel.
7.20.1 RepliCel. Details
7.20.2 RepliCel. Major Business
7.20.3 RepliCel. Engineered Cell Therapy Product and Services
7.20.4 RepliCel. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 RepliCel. Recent Developments/Updates
7.20.6 RepliCel. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Engineered Cell Therapy Industry Chain
8.2 Engineered Cell Therapy Upstream Analysis
8.3 Engineered Cell Therapy Midstream Analysis
8.4 Engineered Cell Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Engineered Cell Therapy Introduction
1.2 World Engineered Cell Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Engineered Cell Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Engineered Cell Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Engineered Cell Therapy Market Size (2018-2029)
1.3.3 China Engineered Cell Therapy Market Size (2018-2029)
1.3.4 Europe Engineered Cell Therapy Market Size (2018-2029)
1.3.5 Japan Engineered Cell Therapy Market Size (2018-2029)
1.3.6 South Korea Engineered Cell Therapy Market Size (2018-2029)
1.3.7 ASEAN Engineered Cell Therapy Market Size (2018-2029)
1.3.8 India Engineered Cell Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Engineered Cell Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Engineered Cell Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Engineered Cell Therapy Consumption Value (2018-2029)
2.2 World Engineered Cell Therapy Consumption Value by Region
2.2.1 World Engineered Cell Therapy Consumption Value by Region (2018-2023)
2.2.2 World Engineered Cell Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Engineered Cell Therapy Consumption Value (2018-2029)
2.4 China Engineered Cell Therapy Consumption Value (2018-2029)
2.5 Europe Engineered Cell Therapy Consumption Value (2018-2029)
2.6 Japan Engineered Cell Therapy Consumption Value (2018-2029)
2.7 South Korea Engineered Cell Therapy Consumption Value (2018-2029)
2.8 ASEAN Engineered Cell Therapy Consumption Value (2018-2029)
2.9 India Engineered Cell Therapy Consumption Value (2018-2029)
3 WORLD ENGINEERED CELL THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World Engineered Cell Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Engineered Cell Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Engineered Cell Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Engineered Cell Therapy in 2022
3.3 Engineered Cell Therapy Company Evaluation Quadrant
3.4 Engineered Cell Therapy Market: Overall Company Footprint Analysis
3.4.1 Engineered Cell Therapy Market: Region Footprint
3.4.2 Engineered Cell Therapy Market: Company Product Type Footprint
3.4.3 Engineered Cell Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Engineered Cell Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Engineered Cell Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Engineered Cell Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Engineered Cell Therapy Consumption Value Comparison
4.2.1 United States VS China: Engineered Cell Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Engineered Cell Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Engineered Cell Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Engineered Cell Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Engineered Cell Therapy Revenue, (2018-2023)
4.4 China Based Companies Engineered Cell Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Engineered Cell Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Engineered Cell Therapy Revenue, (2018-2023)
4.5 Rest of World Based Engineered Cell Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Engineered Cell Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Engineered Cell Therapy Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Engineered Cell Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Synthetic
5.2.2 Biologically Derived
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Engineered Cell Therapy Market Size by Type (2018-2023)
5.3.2 World Engineered Cell Therapy Market Size by Type (2024-2029)
5.3.3 World Engineered Cell Therapy Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Engineered Cell Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Research Institutes
6.2.2 Biotechnological Organizations
6.2.3 Diagnostic Centres
6.3 Market Segment by Application
6.3.1 World Engineered Cell Therapy Market Size by Application (2018-2023)
6.3.2 World Engineered Cell Therapy Market Size by Application (2024-2029)
6.3.3 World Engineered Cell Therapy Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Medtronic
7.1.1 Medtronic Details
7.1.2 Medtronic Major Business
7.1.3 Medtronic Engineered Cell Therapy Product and Services
7.1.4 Medtronic Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Medtronic Recent Developments/Updates
7.1.6 Medtronic Competitive Strengths & Weaknesses
7.2 Stryker
7.2.1 Stryker Details
7.2.2 Stryker Major Business
7.2.3 Stryker Engineered Cell Therapy Product and Services
7.2.4 Stryker Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Stryker Recent Developments/Updates
7.2.6 Stryker Competitive Strengths & Weaknesses
7.3 Zimmer Inc.
7.3.1 Zimmer Inc. Details
7.3.2 Zimmer Inc. Major Business
7.3.3 Zimmer Inc. Engineered Cell Therapy Product and Services
7.3.4 Zimmer Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Zimmer Inc. Recent Developments/Updates
7.3.6 Zimmer Inc. Competitive Strengths & Weaknesses
7.4 Acelity
7.4.1 Acelity Details
7.4.2 Acelity Major Business
7.4.3 Acelity Engineered Cell Therapy Product and Services
7.4.4 Acelity Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Acelity Recent Developments/Updates
7.4.6 Acelity Competitive Strengths & Weaknesses
7.5 Allergan
7.5.1 Allergan Details
7.5.2 Allergan Major Business
7.5.3 Allergan Engineered Cell Therapy Product and Services
7.5.4 Allergan Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Allergan Recent Developments/Updates
7.5.6 Allergan Competitive Strengths & Weaknesses
7.6 Cook Medical
7.6.1 Cook Medical Details
7.6.2 Cook Medical Major Business
7.6.3 Cook Medical Engineered Cell Therapy Product and Services
7.6.4 Cook Medical Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Cook Medical Recent Developments/Updates
7.6.6 Cook Medical Competitive Strengths & Weaknesses
7.7 Baxter International
7.7.1 Baxter International Details
7.7.2 Baxter International Major Business
7.7.3 Baxter International Engineered Cell Therapy Product and Services
7.7.4 Baxter International Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Baxter International Recent Developments/Updates
7.7.6 Baxter International Competitive Strengths & Weaknesses
7.8 Organovo Holdings Inc
7.8.1 Organovo Holdings Inc Details
7.8.2 Organovo Holdings Inc Major Business
7.8.3 Organovo Holdings Inc Engineered Cell Therapy Product and Services
7.8.4 Organovo Holdings Inc Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Organovo Holdings Inc Recent Developments/Updates
7.8.6 Organovo Holdings Inc Competitive Strengths & Weaknesses
7.9 Integra LifeSciences
7.9.1 Integra LifeSciences Details
7.9.2 Integra LifeSciences Major Business
7.9.3 Integra LifeSciences Engineered Cell Therapy Product and Services
7.9.4 Integra LifeSciences Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Integra LifeSciences Recent Developments/Updates
7.9.6 Integra LifeSciences Competitive Strengths & Weaknesses
7.10 DePuy Synthes
7.10.1 DePuy Synthes Details
7.10.2 DePuy Synthes Major Business
7.10.3 DePuy Synthes Engineered Cell Therapy Product and Services
7.10.4 DePuy Synthes Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 DePuy Synthes Recent Developments/Updates
7.10.6 DePuy Synthes Competitive Strengths & Weaknesses
7.11 B. Braun Melsungen AG
7.11.1 B. Braun Melsungen AG Details
7.11.2 B. Braun Melsungen AG Major Business
7.11.3 B. Braun Melsungen AG Engineered Cell Therapy Product and Services
7.11.4 B. Braun Melsungen AG Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 B. Braun Melsungen AG Recent Developments/Updates
7.11.6 B. Braun Melsungen AG Competitive Strengths & Weaknesses
7.12 AbbVie
7.12.1 AbbVie Details
7.12.2 AbbVie Major Business
7.12.3 AbbVie Engineered Cell Therapy Product and Services
7.12.4 AbbVie Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 AbbVie Recent Developments/Updates
7.12.6 AbbVie Competitive Strengths & Weaknesses
7.13 Becton
7.13.1 Becton Details
7.13.2 Becton Major Business
7.13.3 Becton Engineered Cell Therapy Product and Services
7.13.4 Becton Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Becton Recent Developments/Updates
7.13.6 Becton Competitive Strengths & Weaknesses
7.14 Dickinson and Company
7.14.1 Dickinson and Company Details
7.14.2 Dickinson and Company Major Business
7.14.3 Dickinson and Company Engineered Cell Therapy Product and Services
7.14.4 Dickinson and Company Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Dickinson and Company Recent Developments/Updates
7.14.6 Dickinson and Company Competitive Strengths & Weaknesses
7.15 Organogenesis Inc.
7.15.1 Organogenesis Inc. Details
7.15.2 Organogenesis Inc. Major Business
7.15.3 Organogenesis Inc. Engineered Cell Therapy Product and Services
7.15.4 Organogenesis Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Organogenesis Inc. Recent Developments/Updates
7.15.6 Organogenesis Inc. Competitive Strengths & Weaknesses
7.16 Athersys Inc.
7.16.1 Athersys Inc. Details
7.16.2 Athersys Inc. Major Business
7.16.3 Athersys Inc. Engineered Cell Therapy Product and Services
7.16.4 Athersys Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Athersys Inc. Recent Developments/Updates
7.16.6 Athersys Inc. Competitive Strengths & Weaknesses
7.17 ReproCell Inc.
7.17.1 ReproCell Inc. Details
7.17.2 ReproCell Inc. Major Business
7.17.3 ReproCell Inc. Engineered Cell Therapy Product and Services
7.17.4 ReproCell Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 ReproCell Inc. Recent Developments/Updates
7.17.6 ReproCell Inc. Competitive Strengths & Weaknesses
7.18 RTI Surgical Inc.
7.18.1 RTI Surgical Inc. Details
7.18.2 RTI Surgical Inc. Major Business
7.18.3 RTI Surgical Inc. Engineered Cell Therapy Product and Services
7.18.4 RTI Surgical Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 RTI Surgical Inc. Recent Developments/Updates
7.18.6 RTI Surgical Inc. Competitive Strengths & Weaknesses
7.19 Tissue Regenix Group Plc
7.19.1 Tissue Regenix Group Plc Details
7.19.2 Tissue Regenix Group Plc Major Business
7.19.3 Tissue Regenix Group Plc Engineered Cell Therapy Product and Services
7.19.4 Tissue Regenix Group Plc Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Tissue Regenix Group Plc Recent Developments/Updates
7.19.6 Tissue Regenix Group Plc Competitive Strengths & Weaknesses
7.20 RepliCel.
7.20.1 RepliCel. Details
7.20.2 RepliCel. Major Business
7.20.3 RepliCel. Engineered Cell Therapy Product and Services
7.20.4 RepliCel. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 RepliCel. Recent Developments/Updates
7.20.6 RepliCel. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Engineered Cell Therapy Industry Chain
8.2 Engineered Cell Therapy Upstream Analysis
8.3 Engineered Cell Therapy Midstream Analysis
8.4 Engineered Cell Therapy Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Engineered Cell Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Engineered Cell Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Engineered Cell Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Engineered Cell Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Engineered Cell Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Engineered Cell Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Engineered Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Engineered Cell Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Engineered Cell Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Engineered Cell Therapy Players in 2022
Table 12. World Engineered Cell Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Engineered Cell Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Engineered Cell Therapy Player
Table 15. Engineered Cell Therapy Market: Company Product Type Footprint
Table 16. Engineered Cell Therapy Market: Company Product Application Footprint
Table 17. Engineered Cell Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Engineered Cell Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Engineered Cell Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Engineered Cell Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Engineered Cell Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Engineered Cell Therapy Revenue Market Share (2018-2023)
Table 23. China Based Engineered Cell Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Engineered Cell Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Engineered Cell Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Engineered Cell Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Engineered Cell Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Engineered Cell Therapy Revenue Market Share (2018-2023)
Table 29. World Engineered Cell Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Engineered Cell Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Engineered Cell Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Engineered Cell Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Engineered Cell Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Engineered Cell Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. Medtronic Basic Information, Area Served and Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Engineered Cell Therapy Product and Services
Table 38. Medtronic Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medtronic Recent Developments/Updates
Table 40. Medtronic Competitive Strengths & Weaknesses
Table 41. Stryker Basic Information, Area Served and Competitors
Table 42. Stryker Major Business
Table 43. Stryker Engineered Cell Therapy Product and Services
Table 44. Stryker Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Stryker Recent Developments/Updates
Table 46. Stryker Competitive Strengths & Weaknesses
Table 47. Zimmer Inc. Basic Information, Area Served and Competitors
Table 48. Zimmer Inc. Major Business
Table 49. Zimmer Inc. Engineered Cell Therapy Product and Services
Table 50. Zimmer Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Zimmer Inc. Recent Developments/Updates
Table 52. Zimmer Inc. Competitive Strengths & Weaknesses
Table 53. Acelity Basic Information, Area Served and Competitors
Table 54. Acelity Major Business
Table 55. Acelity Engineered Cell Therapy Product and Services
Table 56. Acelity Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Acelity Recent Developments/Updates
Table 58. Acelity Competitive Strengths & Weaknesses
Table 59. Allergan Basic Information, Area Served and Competitors
Table 60. Allergan Major Business
Table 61. Allergan Engineered Cell Therapy Product and Services
Table 62. Allergan Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Allergan Recent Developments/Updates
Table 64. Allergan Competitive Strengths & Weaknesses
Table 65. Cook Medical Basic Information, Area Served and Competitors
Table 66. Cook Medical Major Business
Table 67. Cook Medical Engineered Cell Therapy Product and Services
Table 68. Cook Medical Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Cook Medical Recent Developments/Updates
Table 70. Cook Medical Competitive Strengths & Weaknesses
Table 71. Baxter International Basic Information, Area Served and Competitors
Table 72. Baxter International Major Business
Table 73. Baxter International Engineered Cell Therapy Product and Services
Table 74. Baxter International Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Baxter International Recent Developments/Updates
Table 76. Baxter International Competitive Strengths & Weaknesses
Table 77. Organovo Holdings Inc Basic Information, Area Served and Competitors
Table 78. Organovo Holdings Inc Major Business
Table 79. Organovo Holdings Inc Engineered Cell Therapy Product and Services
Table 80. Organovo Holdings Inc Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Organovo Holdings Inc Recent Developments/Updates
Table 82. Organovo Holdings Inc Competitive Strengths & Weaknesses
Table 83. Integra LifeSciences Basic Information, Area Served and Competitors
Table 84. Integra LifeSciences Major Business
Table 85. Integra LifeSciences Engineered Cell Therapy Product and Services
Table 86. Integra LifeSciences Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Integra LifeSciences Recent Developments/Updates
Table 88. Integra LifeSciences Competitive Strengths & Weaknesses
Table 89. DePuy Synthes Basic Information, Area Served and Competitors
Table 90. DePuy Synthes Major Business
Table 91. DePuy Synthes Engineered Cell Therapy Product and Services
Table 92. DePuy Synthes Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. DePuy Synthes Recent Developments/Updates
Table 94. DePuy Synthes Competitive Strengths & Weaknesses
Table 95. B. Braun Melsungen AG Basic Information, Area Served and Competitors
Table 96. B. Braun Melsungen AG Major Business
Table 97. B. Braun Melsungen AG Engineered Cell Therapy Product and Services
Table 98. B. Braun Melsungen AG Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. B. Braun Melsungen AG Recent Developments/Updates
Table 100. B. Braun Melsungen AG Competitive Strengths & Weaknesses
Table 101. AbbVie Basic Information, Area Served and Competitors
Table 102. AbbVie Major Business
Table 103. AbbVie Engineered Cell Therapy Product and Services
Table 104. AbbVie Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. AbbVie Recent Developments/Updates
Table 106. AbbVie Competitive Strengths & Weaknesses
Table 107. Becton Basic Information, Area Served and Competitors
Table 108. Becton Major Business
Table 109. Becton Engineered Cell Therapy Product and Services
Table 110. Becton Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Becton Recent Developments/Updates
Table 112. Becton Competitive Strengths & Weaknesses
Table 113. Dickinson and Company Basic Information, Area Served and Competitors
Table 114. Dickinson and Company Major Business
Table 115. Dickinson and Company Engineered Cell Therapy Product and Services
Table 116. Dickinson and Company Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Dickinson and Company Recent Developments/Updates
Table 118. Dickinson and Company Competitive Strengths & Weaknesses
Table 119. Organogenesis Inc. Basic Information, Area Served and Competitors
Table 120. Organogenesis Inc. Major Business
Table 121. Organogenesis Inc. Engineered Cell Therapy Product and Services
Table 122. Organogenesis Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Organogenesis Inc. Recent Developments/Updates
Table 124. Organogenesis Inc. Competitive Strengths & Weaknesses
Table 125. Athersys Inc. Basic Information, Area Served and Competitors
Table 126. Athersys Inc. Major Business
Table 127. Athersys Inc. Engineered Cell Therapy Product and Services
Table 128. Athersys Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Athersys Inc. Recent Developments/Updates
Table 130. Athersys Inc. Competitive Strengths & Weaknesses
Table 131. ReproCell Inc. Basic Information, Area Served and Competitors
Table 132. ReproCell Inc. Major Business
Table 133. ReproCell Inc. Engineered Cell Therapy Product and Services
Table 134. ReproCell Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. ReproCell Inc. Recent Developments/Updates
Table 136. ReproCell Inc. Competitive Strengths & Weaknesses
Table 137. RTI Surgical Inc. Basic Information, Area Served and Competitors
Table 138. RTI Surgical Inc. Major Business
Table 139. RTI Surgical Inc. Engineered Cell Therapy Product and Services
Table 140. RTI Surgical Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. RTI Surgical Inc. Recent Developments/Updates
Table 142. RTI Surgical Inc. Competitive Strengths & Weaknesses
Table 143. Tissue Regenix Group Plc Basic Information, Area Served and Competitors
Table 144. Tissue Regenix Group Plc Major Business
Table 145. Tissue Regenix Group Plc Engineered Cell Therapy Product and Services
Table 146. Tissue Regenix Group Plc Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Tissue Regenix Group Plc Recent Developments/Updates
Table 148. RepliCel. Basic Information, Area Served and Competitors
Table 149. RepliCel. Major Business
Table 150. RepliCel. Engineered Cell Therapy Product and Services
Table 151. RepliCel. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Engineered Cell Therapy Upstream (Raw Materials)
Table 153. Engineered Cell Therapy Typical Customers
Table 1. World Engineered Cell Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Engineered Cell Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Engineered Cell Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Engineered Cell Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Engineered Cell Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Engineered Cell Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Engineered Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Engineered Cell Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Engineered Cell Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Engineered Cell Therapy Players in 2022
Table 12. World Engineered Cell Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Engineered Cell Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Engineered Cell Therapy Player
Table 15. Engineered Cell Therapy Market: Company Product Type Footprint
Table 16. Engineered Cell Therapy Market: Company Product Application Footprint
Table 17. Engineered Cell Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Engineered Cell Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Engineered Cell Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Engineered Cell Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Engineered Cell Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Engineered Cell Therapy Revenue Market Share (2018-2023)
Table 23. China Based Engineered Cell Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Engineered Cell Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Engineered Cell Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Engineered Cell Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Engineered Cell Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Engineered Cell Therapy Revenue Market Share (2018-2023)
Table 29. World Engineered Cell Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Engineered Cell Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Engineered Cell Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Engineered Cell Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Engineered Cell Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Engineered Cell Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. Medtronic Basic Information, Area Served and Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Engineered Cell Therapy Product and Services
Table 38. Medtronic Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medtronic Recent Developments/Updates
Table 40. Medtronic Competitive Strengths & Weaknesses
Table 41. Stryker Basic Information, Area Served and Competitors
Table 42. Stryker Major Business
Table 43. Stryker Engineered Cell Therapy Product and Services
Table 44. Stryker Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Stryker Recent Developments/Updates
Table 46. Stryker Competitive Strengths & Weaknesses
Table 47. Zimmer Inc. Basic Information, Area Served and Competitors
Table 48. Zimmer Inc. Major Business
Table 49. Zimmer Inc. Engineered Cell Therapy Product and Services
Table 50. Zimmer Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Zimmer Inc. Recent Developments/Updates
Table 52. Zimmer Inc. Competitive Strengths & Weaknesses
Table 53. Acelity Basic Information, Area Served and Competitors
Table 54. Acelity Major Business
Table 55. Acelity Engineered Cell Therapy Product and Services
Table 56. Acelity Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Acelity Recent Developments/Updates
Table 58. Acelity Competitive Strengths & Weaknesses
Table 59. Allergan Basic Information, Area Served and Competitors
Table 60. Allergan Major Business
Table 61. Allergan Engineered Cell Therapy Product and Services
Table 62. Allergan Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Allergan Recent Developments/Updates
Table 64. Allergan Competitive Strengths & Weaknesses
Table 65. Cook Medical Basic Information, Area Served and Competitors
Table 66. Cook Medical Major Business
Table 67. Cook Medical Engineered Cell Therapy Product and Services
Table 68. Cook Medical Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Cook Medical Recent Developments/Updates
Table 70. Cook Medical Competitive Strengths & Weaknesses
Table 71. Baxter International Basic Information, Area Served and Competitors
Table 72. Baxter International Major Business
Table 73. Baxter International Engineered Cell Therapy Product and Services
Table 74. Baxter International Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Baxter International Recent Developments/Updates
Table 76. Baxter International Competitive Strengths & Weaknesses
Table 77. Organovo Holdings Inc Basic Information, Area Served and Competitors
Table 78. Organovo Holdings Inc Major Business
Table 79. Organovo Holdings Inc Engineered Cell Therapy Product and Services
Table 80. Organovo Holdings Inc Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Organovo Holdings Inc Recent Developments/Updates
Table 82. Organovo Holdings Inc Competitive Strengths & Weaknesses
Table 83. Integra LifeSciences Basic Information, Area Served and Competitors
Table 84. Integra LifeSciences Major Business
Table 85. Integra LifeSciences Engineered Cell Therapy Product and Services
Table 86. Integra LifeSciences Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Integra LifeSciences Recent Developments/Updates
Table 88. Integra LifeSciences Competitive Strengths & Weaknesses
Table 89. DePuy Synthes Basic Information, Area Served and Competitors
Table 90. DePuy Synthes Major Business
Table 91. DePuy Synthes Engineered Cell Therapy Product and Services
Table 92. DePuy Synthes Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. DePuy Synthes Recent Developments/Updates
Table 94. DePuy Synthes Competitive Strengths & Weaknesses
Table 95. B. Braun Melsungen AG Basic Information, Area Served and Competitors
Table 96. B. Braun Melsungen AG Major Business
Table 97. B. Braun Melsungen AG Engineered Cell Therapy Product and Services
Table 98. B. Braun Melsungen AG Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. B. Braun Melsungen AG Recent Developments/Updates
Table 100. B. Braun Melsungen AG Competitive Strengths & Weaknesses
Table 101. AbbVie Basic Information, Area Served and Competitors
Table 102. AbbVie Major Business
Table 103. AbbVie Engineered Cell Therapy Product and Services
Table 104. AbbVie Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. AbbVie Recent Developments/Updates
Table 106. AbbVie Competitive Strengths & Weaknesses
Table 107. Becton Basic Information, Area Served and Competitors
Table 108. Becton Major Business
Table 109. Becton Engineered Cell Therapy Product and Services
Table 110. Becton Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Becton Recent Developments/Updates
Table 112. Becton Competitive Strengths & Weaknesses
Table 113. Dickinson and Company Basic Information, Area Served and Competitors
Table 114. Dickinson and Company Major Business
Table 115. Dickinson and Company Engineered Cell Therapy Product and Services
Table 116. Dickinson and Company Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Dickinson and Company Recent Developments/Updates
Table 118. Dickinson and Company Competitive Strengths & Weaknesses
Table 119. Organogenesis Inc. Basic Information, Area Served and Competitors
Table 120. Organogenesis Inc. Major Business
Table 121. Organogenesis Inc. Engineered Cell Therapy Product and Services
Table 122. Organogenesis Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Organogenesis Inc. Recent Developments/Updates
Table 124. Organogenesis Inc. Competitive Strengths & Weaknesses
Table 125. Athersys Inc. Basic Information, Area Served and Competitors
Table 126. Athersys Inc. Major Business
Table 127. Athersys Inc. Engineered Cell Therapy Product and Services
Table 128. Athersys Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Athersys Inc. Recent Developments/Updates
Table 130. Athersys Inc. Competitive Strengths & Weaknesses
Table 131. ReproCell Inc. Basic Information, Area Served and Competitors
Table 132. ReproCell Inc. Major Business
Table 133. ReproCell Inc. Engineered Cell Therapy Product and Services
Table 134. ReproCell Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. ReproCell Inc. Recent Developments/Updates
Table 136. ReproCell Inc. Competitive Strengths & Weaknesses
Table 137. RTI Surgical Inc. Basic Information, Area Served and Competitors
Table 138. RTI Surgical Inc. Major Business
Table 139. RTI Surgical Inc. Engineered Cell Therapy Product and Services
Table 140. RTI Surgical Inc. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. RTI Surgical Inc. Recent Developments/Updates
Table 142. RTI Surgical Inc. Competitive Strengths & Weaknesses
Table 143. Tissue Regenix Group Plc Basic Information, Area Served and Competitors
Table 144. Tissue Regenix Group Plc Major Business
Table 145. Tissue Regenix Group Plc Engineered Cell Therapy Product and Services
Table 146. Tissue Regenix Group Plc Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Tissue Regenix Group Plc Recent Developments/Updates
Table 148. RepliCel. Basic Information, Area Served and Competitors
Table 149. RepliCel. Major Business
Table 150. RepliCel. Engineered Cell Therapy Product and Services
Table 151. RepliCel. Engineered Cell Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Engineered Cell Therapy Upstream (Raw Materials)
Table 153. Engineered Cell Therapy Typical Customers
LIST OF FIGURES
Figure 1. Engineered Cell Therapy Picture
Figure 2. World Engineered Cell Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Engineered Cell Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Engineered Cell Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Engineered Cell Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Engineered Cell Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Engineered Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Engineered Cell Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Engineered Cell Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Engineered Cell Therapy Markets in 2022
Figure 27. United States VS China: Engineered Cell Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Engineered Cell Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Engineered Cell Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Engineered Cell Therapy Market Size Market Share by Type in 2022
Figure 31. Synthetic
Figure 32. Biologically Derived
Figure 33. Others
Figure 34. World Engineered Cell Therapy Market Size Market Share by Type (2018-2029)
Figure 35. World Engineered Cell Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Engineered Cell Therapy Market Size Market Share by Application in 2022
Figure 37. Research Institutes
Figure 38. Biotechnological Organizations
Figure 39. Diagnostic Centres
Figure 40. Engineered Cell Therapy Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Engineered Cell Therapy Picture
Figure 2. World Engineered Cell Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Engineered Cell Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Engineered Cell Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Engineered Cell Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Engineered Cell Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Engineered Cell Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Engineered Cell Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Engineered Cell Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Engineered Cell Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Engineered Cell Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Engineered Cell Therapy Markets in 2022
Figure 27. United States VS China: Engineered Cell Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Engineered Cell Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Engineered Cell Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Engineered Cell Therapy Market Size Market Share by Type in 2022
Figure 31. Synthetic
Figure 32. Biologically Derived
Figure 33. Others
Figure 34. World Engineered Cell Therapy Market Size Market Share by Type (2018-2029)
Figure 35. World Engineered Cell Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Engineered Cell Therapy Market Size Market Share by Application in 2022
Figure 37. Research Institutes
Figure 38. Biotechnological Organizations
Figure 39. Diagnostic Centres
Figure 40. Engineered Cell Therapy Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
